Who looks? BCRI11 by screener sees a DY of 16,38% and a P/VP of 0,71 and thinks of bargain. Who opens the management report sees something else: nine stressed positions adding 14,21% of net worth, spread in situations ranging from "paying interest only" to "execution of 55 pawned units". The unit discount has motive. The DY also — it has already dropped 20% in the last four months, from R$ 0,92 to the current R$ 0,74, by deflation of IPCA and IGP-M. The question is not whether the unit is cheap. It's if it's cheap enough for what's inside.
DPS has already dropped 28% in four months
O BCRI11 I distributed R$ 0,92/unit four months ago. Today pays R$ 0,74 — fall of 28%. The cause is not new default, it is deflation: the portfolio is mostly indexed to IPCA and IGP-M, and when the indices turn negative in the month, the result of CRIs shrinks. It's a feature of the fund, not an accident. For the quotaist who bought it by the yield designed in January, the May extract already comes with less than a fifth.
The 9 wounds of the portfolio
These 14,21% are not a unique list of "attention". It's nine different stories, each with one kind of problem. They go from still technically healthy operation (CRI PESA, with sale of property-guarantee extended for the fourth time) to actual execution in progress (CRI Artenge, with 55 pawned units). It is the sum of these stories that justifies the asset discount — and the eventual trigger that can increase it.
The discount of 28% has motive — but it also has logic
The market is not irrational here. A portfolio with stress 14,21% does not negotiate with VP, and would never negotiate. The right question is, is the discount calibrated to the size of the problem? If the fund manager resolves half of these nine positions fully recovering the principal — which is reasonable given the vehicle history and the presence of real guarantees in several CRIs — the gap closes. If you lose main in three or four of the largest (PESA, WAM, GVI add up almost 8% of the PL), the discount can increase before closing.
The thesis of those who buy BCRI11 He has three legs today. The first is the spread over Selic of about 93 bps net — modest, but free from IR over the dividend. The second is the security margin in the price: pay R$ 60,17 for a R$ 85,05 equity gives breath to support partial main loss without staying below the entrance. The third is the track record of the vehicle: 11 years operating, with management that has already undergone other cycles of default in CRI and historically achieved significant recovery through execution of guarantees.
RAP Recommendation: KEEP, note 6,5
It's not SALE. The 28% discount on VP and PL size (R$ 532,2 Mi distributed between 41.307 unit holders) give real margin. Exiting paper now holds accounting loss for no definite reason — none of the nine crises is confirmed as total loss. He's not strong, either. Buying more BCRI11 today is betting that the sum of nine small problems will be smaller than it seems — a reasonable bet in average probability, but it does not have premium compatible with asymmetric risk (a relevant RJ drops the asset discount, several clean resolutions close the gap slowly). KEEPING is the right verdict for those who already have a position. For those who do not, there are paper FIIs with cleaner portfolio negotiating the similar P/VP.
Who buys BCRI11 today is betting that the fund manager will solve at least half of the nine crises without losing main — and eleven years track record is the only real argument in favor. The other numbers (DY 16%, P/VP 0,71, spread over Selic) describe the photograph of a discounted unit, not the probability of the fund manager winning nine simultaneous disputes. The unitholder who enters today is not buying income or discount: he is buying trust in a team that will work in execution for the next two years.
